US Stock MarketDetailed Quotes
HURA TuHURA Biosciences
- 6.480
- +1.430+28.32%
Trading Nov 29 12:26 ET
274.00MMarket Cap-5538P/E (TTM)
6.990High5.320Low1.66MVolume5.510Open5.050Pre Close10.69MTurnover6.23%Turnover RatioLossP/E (Static)42.28MShares14.59552wk High14.37P/B172.82MFloat Cap2.83552wk Low--Dividend TTM26.67MShs Float238000.000Historical High--Div YieldTTM33.07%Amplitude2.835Historical Low6.429Avg Price1Lot Size
TuHURA Biosciences Key Stats
Quarterly+Annual
YOY
| (Q1)Sep 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||||
| Cash flow from continuing operating activities | 41.57%-1.89M | -18.60%-3.83M | -59.17%-11.95M | -74.58%-3.23M | -14.40%-7.51M | -1.85M | -6.56M |
| Net income from continuing operations | 88.45%-2.16M | 74.12%-4.84M | -212.96%-29.32M | -778.02%-18.71M | -33.51%-9.37M | ---2.13M | ---7.02M |
| Operating gains losses | ---- | ---12.09K | ---- | ---- | 27.36%-294.07K | ---- | ---404.85K |
| Depreciation and amortization | -71.88%17K | -43.24%34.31K | -52.46%177.38K | -35.70%60.45K | -2.00%373.09K | --94.01K | --380.69K |
| Other non cash items | ---- | --17.38K | --5.12K | ---- | ---- | ---- | --629.29K |
| Change In working capital | 115.93%152K | 166.43%633.7K | -68.83%486.92K | -711.09%-953.95K | 421.26%1.56M | --156.11K | ---486.2K |
| -Change in prepaid assets | --156K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | 99.67%-4K | 156.86%691.88K | -81.73%337.75K | -984.63%-1.22M | 493.01%1.85M | --137.55K | ---470.34K |
| -Change in other current assets | ---- | -122.13%-58.19K | 152.07%149.18K | 1,316.83%262.88K | -3,455.35%-286.51K | --18.55K | --8.54K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---24.4K |
| Cash from discontinued investing activities | |||||||
| Operating cash flow | 41.57%-1.89M | -18.60%-3.83M | -59.17%-11.95M | -74.58%-3.23M | -14.40%-7.51M | ---1.85M | ---6.56M |
| Investing cash flow | |||||||
| Cash flow from continuing investing activities | 0 | -3,474.93%-1.3M | -1.2M | -1,006.01%-36.28K | 0 | -3.28K | |
| Net PPE purchase and sale | ---- | ---- | -118.39%-79.22K | ---- | -1,006.01%-36.28K | ---- | ---3.28K |
| Net business purchase and sale | ---- | --0 | ---1.22M | ---1.2M | --0 | --0 | ---- |
| Cash from discontinued investing activities | |||||||
| Investing cash flow | ---- | --0 | -3,474.93%-1.3M | ---1.2M | -1,006.01%-36.28K | --0 | ---3.28K |
| Financing cash flow | |||||||
| Cash flow from continuing financing activities | 0 | 4.63M | -83.63%2.66M | 0 | 130.69%16.25M | -150K | 7.04M |
| Net issuance payments of debt | ---- | --4.9M | 867.14%2.69M | --0 | -219.02%-350K | ---150K | --294.07K |
| Net common stock issuance | ---- | ---- | ---24.75K | ---- | --0 | ---- | --5.6M |
| Net preferred stock issuance | ---- | ---- | --0 | ---- | 1,342.98%16.6M | ---- | --1.15M |
| Cash dividends paid | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---272.3K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | |||||||
| Financing cash flow | --0 | --4.63M | -83.63%2.66M | --0 | 130.69%16.25M | ---150K | --7.04M |
| Net cash flow | |||||||
| Beginning cash position | -65.56%4.91M | -74.29%3.67M | 156.98%14.25M | 156.98%14.25M | 9.43%5.55M | --5.55M | --5.07M |
| Current changes in cash | 57.39%-1.89M | 117.97%796.46K | -221.60%-10.59M | -121.45%-4.43M | 1,721.77%8.71M | ---2M | --477.91K |
| End cash Position | -69.25%3.02M | -54.57%4.46M | -74.29%3.67M | 177.06%9.82M | 156.98%14.25M | --3.54M | --5.55M |
| Free cash flow | 41.57%-1.89M | -18.60%-3.83M | -59.45%-12.03M | -74.58%-3.23M | -14.89%-7.54M | ---1.85M | ---6.57M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
